238 related articles for article (PubMed ID: 15475228)
21. [Obesity in children and adolescents and diabetes].
Nazim J; Starzyk J
Przegl Lek; 2009; 66(1-2):96-9. PubMed ID: 19485265
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome: screening, diagnosis, and management.
Miller EL; Mitchell A
J Midwifery Womens Health; 2006; 51(3):141-51. PubMed ID: 16647666
[TBL] [Abstract][Full Text] [Related]
23. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella NA
Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
[TBL] [Abstract][Full Text] [Related]
24. Effective treatments for insulin resistance: trim the fat and douse the fire.
Evans JL; Youngren JF; Goldfine ID
Trends Endocrinol Metab; 2004 Nov; 15(9):425-31. PubMed ID: 15519889
[TBL] [Abstract][Full Text] [Related]
25. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
[TBL] [Abstract][Full Text] [Related]
26. Type 2 diabetes mellitus in childhood: obesity and insulin resistance.
Schwartz MS; Chadha A
J Am Osteopath Assoc; 2008 Sep; 108(9):518-24. PubMed ID: 18806081
[TBL] [Abstract][Full Text] [Related]
27. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
Lteif A; Mather K
Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome and its components after liver transplantation: incidence, prevalence, risk factors, and implications.
Anastácio LR; Lima AS; Toulson Davisson Correia MI
Clin Nutr; 2010 Apr; 29(2):175-9. PubMed ID: 19783330
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
30. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
31. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Nathanson D; Nyström T
Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance in patients with polycystic ovary syndrome.
Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
[TBL] [Abstract][Full Text] [Related]
33. Human obesity and insulin resistance: lessons from experiments of nature.
O'Rahilly S
Novartis Found Symp; 2007; 286():13-20; discussion 20-3, 162-3, 196-203. PubMed ID: 18269171
[TBL] [Abstract][Full Text] [Related]
34. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of insulin resistance syndrome in a primary health care center in Kuwait.
Al-Shaibani H; El-Batish M; Sorkhou I; Al-Shamali N; Al-Namash H; Habiba S; Al-Qallaf B
Fam Med; 2004 Sep; 36(8):540. PubMed ID: 15343411
[No Abstract] [Full Text] [Related]
36. Metabolic and respiratory comorbidities of childhood obesity.
Fennoy I
Pediatr Ann; 2010 Mar; 39(3):140-6. PubMed ID: 20302245
[No Abstract] [Full Text] [Related]
37. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
[TBL] [Abstract][Full Text] [Related]
38. The metabolic syndrome and its cardiovascular manifestations.
Sánchez-Torres RJ; Delgado-Osorio H
Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
[TBL] [Abstract][Full Text] [Related]
39. Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.
Pasquali R; Gambineri A
Expert Opin Ther Targets; 2009 Oct; 13(10):1205-26. PubMed ID: 19650762
[TBL] [Abstract][Full Text] [Related]
40. Metabolic syndrome and heart failure.
Thethi T; Bratcher C; Fonseca V
Heart Fail Clin; 2006 Jan; 2(1):1-11. PubMed ID: 17386872
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
